LIFEMD, INC. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- LIFEMD, INC. stock issued during period, value, stock options exercised for the quarter ending 2026-03-31 was $80.52K.
- LIFEMD, INC. stock issued during period, value, stock options exercised for the quarter ending 2025-09-30 was $5.95K.
- LIFEMD, INC. stock issued during period, value, stock options exercised for the quarter ending 2024-06-30 was $100.00K.
- LIFEMD, INC. stock issued during period, value, stock options exercised for the quarter ending 2024-03-31 was $7.81K.
- LIFEMD, INC. stock issued during period, value, stock options exercised for fiscal 2025 was $5.95K, a 95.05% decline from fiscal 2024.
- LIFEMD, INC. stock issued during period, value, stock options exercised for fiscal 2024 was $120.31K, a 27.31% increase from fiscal 2023.
- LIFEMD, INC. stock issued during period, value, stock options exercised for fiscal 2023 was $94.50K, a 4.54% increase from fiscal 2022.
- LIFEMD, INC. stock issued during period, value, stock options exercised for fiscal 2022 was $90.40K, a 86.52% decline from fiscal 2021.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-03-31 | $80.52K 10-Q · filed 2026-08-05 | |
| 2025-12-31 | $5.95K 10-K · filed 2026-03-10 | |
| 2025-09-30 | $5.95K 10-Q · filed 2025-11-17 | |
| 2024-12-31 | $120.31K 10-K · filed 2026-03-10 | |
| 2024-06-30 | $100.00K 10-Q · filed 2025-11-17 | |
| 2024-03-31 | $7.81K 10-Q · filed 2025-11-17 | |
| 2023-12-31 | $94.50K 10-K · filed 2025-03-11 | |
| 2022-12-31 | $90.40K 10-K · filed 2024-03-11 | |
| 2022-06-30 | $90.40K 10-Q · filed 2023-11-08 | |
| 2021-12-31 | $670.75K 10-K · filed 2023-03-22 | |
| 2021-09-30 | $54.00K 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $742.75K 10-Q · filed 2022-11-10 | |
| 2021-03-31 | $24.00K 10-Q · filed 2022-11-10 | |
| 2020-12-31 | $302.40K 10-K · filed 2022-03-07 | |
| 2020-09-30 | $300.40K 10-Q · filed 2021-11-10 | |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $4.08K 10-K · filed 2020-03-30 |
| 2018-09-30 | $4.08K 10-Q · filed 2019-11-14 | |
| 2016-12-31 | $30.00K 10-K · filed 2018-04-02 | |
| 2013-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-28 | $50.00K 10-K · filed 2014-03-28 |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | |
| 2012-12-31 | $32.50K 10-K · filed 2014-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Airsculpt Technologies, Inc. (AIRS) | United States | $0.146B | -27.36 |
| SBC Medical Group Holdings Inc (SBC) | United States | $0.487B | |
| Teladoc Health, Inc. (TDOC) | United States | $1.114B | -8.68 |